These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7708453)

  • 21. Using normal saline to lock peripheral intravenous catheters in ambulatory cancer patients.
    Kamitomo V; Olson K
    J Intraven Nurs; 1996; 19(2):75-8. PubMed ID: 8852166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M; Heijboer H; van Woensel JB; de Haan RJ
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of the POP technique for restoring patency to occluded PIC catheters.
    Fetzer SJ; Manning GP
    Appl Nurs Res; 2004 Nov; 17(4):297-300. PubMed ID: 15573339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the research about heparinized versus nonheparinized intravascular lines.
    Peterson FY; Kirchhoff KT
    Heart Lung; 1991 Nov; 20(6):631-40. PubMed ID: 1835721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin vs saline for intermittent intravenous device maintenance in neonates.
    Kotter RW
    Neonatal Netw; 1996 Sep; 15(6):43-7. PubMed ID: 8932071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saline for peripheral intravenous locks in neonates: evaluating a change in practice.
    Hanrahan KS; Kleiber C; Berends S
    Neonatal Netw; 2000 Mar; 19(2):19-24. PubMed ID: 11948994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA; Plis JM; Clay C; Sylvan L
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric peripherally inserted central catheter program report: a summary of 4,536 catheter days.
    Frey AM
    J Intraven Nurs; 1995; 18(6):280-91. PubMed ID: 8699286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous access. Part 1. Peripheral i.v.s.
    Rostad M
    Urol Nurs; 1992 Mar; 12(1):18-22. PubMed ID: 1542798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of normal or heparinised saline flushing on function of arterial lines.
    Whitta RK; Hall KF; Bennetts TM; Welman L; Rawlins P
    Crit Care Resusc; 2006 Sep; 8(3):205-8. PubMed ID: 16930104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children.
    LeDuc K
    J Emerg Nurs; 1997 Aug; 23(4):306-9. PubMed ID: 9379571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of peripheral vein complications: evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention.
    Myrianthefs P; Sifaki M; Samara I; Baltopoulos G
    J Eval Clin Pract; 2005 Feb; 11(1):85-9. PubMed ID: 15660542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching from heparinized saline flush to normal saline flush for maintaining peripheral venous catheter patency.
    Thamlikitkul V; Indranoi A
    Int J Qual Health Care; 2006 Jun; 18(3):183-5. PubMed ID: 16766602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why flush peripheral intravenous cannulae used for intermittent intravenous injection?
    Walsh DA; Toeg D; Mellor JA
    Br J Clin Pract; 1991; 45(1):31-2. PubMed ID: 1931537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of percutaneous venous catheters and teflon catheters for intravenous therapy in neonates.
    Reynolds J
    Neonatal Netw; 1993 Aug; 12(5):33-9. PubMed ID: 8350847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patency of radial arterial catheters.
    Kaye J; Heald GR; Morton J; Weaver T
    Am J Crit Care; 2001 Mar; 10(2):104-11. PubMed ID: 11244667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times.
    Homer LD; Holmes KR
    J Intraven Nurs; 1998; 21(5):301-5. PubMed ID: 9814284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving practice through research: the case of heparin vs. saline for peripheral intermittent infusion devices.
    Goode CJ; Kleiber C; Titler M; Small S; Rakel B; Steelman VM; Walker JB; Buckwalter KC
    Medsurg Nurs; 1993 Feb; 2(1):23-7. PubMed ID: 8319047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines: the AACN Thunder Project. By the American Association of Critical-Care Nurses.
    Am J Crit Care; 1993 Jan; 2(1):3-15. PubMed ID: 8353575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial.
    Klenner AF; Fusch C; Rakow A; Kadow I; Beyersdorff E; Eichler P; Wander K; Lietz T; Greinacher A
    J Pediatr; 2003 Dec; 143(6):741-5. PubMed ID: 14657819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.